ReproNovo
Company Details
Status: Private
Employees: 11-50
Location:
Rue de Langallerie 11, Lausanne, 1003, CH
Type:
sample
Technology:
sample
sample
About: At ReproNovo, we are redefining what's possible in reproductive medicine and women's health.
We are advancing innovative therapeutic solutions for both male and female infertility, as well as pioneering treatment options for uterine conditions like adenomyosis, delivering meaningful change to patients worldwide.
Our international team brings together deep expertise across reproductive medicine, drug development, regulatory strategy, and business developmentâwith a proven track record of bringing multiple therapies to market.
ReproNovo is backed by leading investors including Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, and ALSA Ventures. Headquartered in Lausanne, Switzerland, our primary development team is located in Copenhagen, Denmark, with an additional development site in Barcelona, Spain.
Imprint
ReproNovo S.A.
Rue de Langallerie 11
1003 Lausanne, Switzerland
E-Mail: info@repronovo.com
Chief Executive Officer & Co-Founder: Jean Duvall
Chief Scientific & Medical Officer & Co-Founder: Joan-Carles Arce
Chief Financial Officer & Co-Founder: BingMei Hao
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ReproNovo | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.